Skip to main content
Erschienen in: Reactions Weekly 1/2023

01.12.2023 | Case report

Lutetium-(177lu)-oxodotreotide

Lymphocytopenia: case report

Erschienen in: Reactions Weekly | Ausgabe 1/2023

Einloggen, um Zugang zu erhalten

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literatur
Zurück zum Zitat Minczeles NS, et al. Efficacy and safety of peptide receptor radionuclide therapy with [177Lu]Lu-DOTA-TATE in 15 patients with progressive treatment-refractory meningioma. European Journal of Nuclear Medicine and Molecular Imaging 50: 1195-1204, No. 4, Mar 2023. Available from: URL: https://www.springer.com/journal/259 Minczeles NS, et al. Efficacy and safety of peptide receptor radionuclide therapy with [177Lu]Lu-DOTA-TATE in 15 patients with progressive treatment-refractory meningioma. European Journal of Nuclear Medicine and Molecular Imaging 50: 1195-1204, No. 4, Mar 2023. Available from: URL: https://​www.​springer.​com/​journal/​259
Metadaten
Titel
Lutetium-(177lu)-oxodotreotide
Lymphocytopenia: case report
Publikationsdatum
01.12.2023
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2023
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-023-51882-4

Weitere Artikel der Ausgabe 1/2023

Reactions Weekly 1/2023 Zur Ausgabe

Case report

Multiple drugs

Case report

Stanozolol

Case report

Adenosine

Case report

Carfilzomib